Home / Share Price Target / Aareydrugs
AAREYDRUGS Share Price Target 2024, 2025, 2026 to 2039 With Charts
Aarey Drugs & Pharmaceuticals Limited | |||
 | Symbol: AAREYDRUGS | ||
| Price: ₹56.3 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: AAREYDRUGS Brief Company Overview
- 1.1: Company Overview: Aarey Drugs & Pharmaceuticals Limited
- 1.2: AAREYDRUGS Financial Performance
- 1.2.1: Is AAREYDRUGS A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: AAREYDRUGS Share Price Target For 2024
- 2.1.1: AAREYDRUGS Share Price Target Table For 2024
- 2.1.2: Summary: AAREYDRUGS Share Price Prediction For 2024
- 2.2: AAREYDRUGS Share Price Target For 2025
- 2.2.1: AAREYDRUGS Share Price Target Table For 2025
- 2.2.2: Summary: AAREYDRUGS Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: AAREYDRUGS Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: AAREYDRUGS Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: AAREYDRUGS Past Performance
AAREYDRUGS Brief Company Overview
Company Overview: Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited, established in 1990, is a reputable manufacturer and supplier of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals in India. The company has a diverse product portfolio:
- APIs: Metformin HCL, Mefenamic Acid, Doxophylline
- Chemicals and Solvents: Aromatic Chemicals, Chemical Acids, Chlor Alkalies, Glycols, Acetates, Esters
Aarey Drugs & Pharmaceuticals Limited caters to pharmaceutical formulation manufacturers and exporters. The company is committed to providing high-quality products and services, making it a trusted name in the industry.
AAREYDRUGS Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 181.46 Crore | Market valuation of AAREYDRUGS's shares. |
| Revenue (TTM) | 471.57 Crore | Total revenue generated by AAREYDRUGS over the past twelve months. |
| Net Income (TTM) | +5.19 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 0.56% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 1.1% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +149.1% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +71% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 23.61 | Company's total debt divided by total shareholder equity. |
| Total Debt | 31.35 Crore | Sum of AAREYDRUGS's current & long-term financial obligations. |
| Total Cash | 2.89 Crore | Total amount of liquid funds available to AAREYDRUGS. |
| Beta | 0.92 | Beta is less than 1 indicating that the AAREYDRUGS's price is less volatile than the market. |
Is AAREYDRUGS A Good Buy For Long Term?
AAREYDRUGS, a small-cap stock with a market capitalization of ₹170.72 crore, presents a mixed picture for long-term investors. While its revenue reached ₹471.57 crore in the last twelve months (TTM), with a significant 149.1% quarter-on-quarter growth, the net profit margin of only 1.1% is concerning. The substantial year-on-year earnings increase (71%) is positive, but the company carries ₹31.35 crore in debt against a mere ₹2.89 crore cash balance (Q1 2024-25). Past returns show volatility, with strong short-term performance but no growth over 3 or 5 years. Therefore, it's currently an average buy, requiring further due diligence before committing to a long-term investment.
To predict the AAREYDRUGS's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
AAREYDRUGS Share Price Target For 2024
The line chart displays the monthly closing prices of AAREYDRUGS with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for AAREYDRUGS shares in 2024, see the table below.
AAREYDRUGS Share Price Target Table For 2024
| AAREYDRUGS's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 56.44 (+0.24%) | Custom Fibonacci Extension Lvl 82% |
| 2024 Target 2 | 55.76 (-0.96%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 1 | 55.19 (-1.98%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 56.30 | AAREYDRUGS's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 54.54 (-3.13%) | Price Action: Chart |
| Stop Loss 2 | 53.86 (-4.34%) | Fibonacci Retracement Level 71.8% |
| Stop Loss 3 | 53.29 (-5.35%) | Fibonacci Retracement Level 98.6% |
Summary: AAREYDRUGS Share Price Prediction For 2024
In summary, AAREYDRUGS has surged by ₹4.14, achieving a notable +8.19% increase from 1st January 2024 to 22 Nov 2024. Our analysis of AAREYDRUGS for 2024 predicts an additional rise of -1.98% to 0.24% by the end of 2024 with three potential targets T1: 55.19, T2: 55.76, T3: 56.44. Stop Loss at SL1: 54.54, SL2: 53.86, SL3: 53.29.
AAREYDRUGS has a 52-week high of ₹74.80, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹37.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for AAREYDRUGS.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
AAREYDRUGS Share Price Target For 2025
The line chart displays the monthly closing prices of AAREYDRUGS with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for AAREYDRUGS shares in 2025, see the table below.
AAREYDRUGS Share Price Target Table For 2025
| AAREYDRUGS's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 79.99 (+42.07%) | Price Action: Chart |
| 2025 Target 2 | 78.50 (+39.43%) | Price Action: Chart |
| 2025 Target 1 | 77.72 (+38.04%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 56.30 | AAREYDRUGS's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 49.30 (-12.44%) | Price Action: Jul 2024 Low |
| Stop Loss 2 | 48.81 (-13.31%) | Price Action: Chart |
| Stop Loss 3 | 48.00 (-14.75%) | Price Action: Jun 2024 High |
Summary: AAREYDRUGS Share Price Prediction For 2025
In summary, AAREYDRUGS has surged by ₹4.14, achieving a notable +8.19% increase from 1st January 2024 to 22 Nov 2024. Our analysis of AAREYDRUGS for 2025 predicts an additional rise of 38.04% to 42.07% by the end of 2025 with three potential targets T1: 77.72, T2: 78.50, T3: 79.99. Stop Loss at SL1: 49.30, SL2: 48.81, SL3: 48.00.
AAREYDRUGS has a All-Time high of ₹74.80, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹37.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for AAREYDRUGS, we have created a specific page for that check here: AAREYDRUGS Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
AAREYDRUGS Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of AAREYDRUGS share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 11.75% over the next 15 years.
For complete year by year AAREYDRUGS long term share price target from 2024, 2025 to 2039 check the below table.
AAREYDRUGS Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | AAREYDRUGS Target | YoY Change % |
|---|---|---|
| 2024 | ₹56.3 | [Current Price] |
| 2024 | ₹62.54 | 11.08% |
| 2025 | ₹81.13 | 29.72% |
| 2026 | ₹98.14 | 20.96% |
| 2027 | ₹109.11 | 11.17% |
| 2028 | ₹126.7 | 16.12% |
| 2029 | ₹139.44 | 10.05% |
| 2030 | ₹161.19 | 15.59% |
| 2031 | ₹179.02 | 11.06% |
| 2032 | ₹186.3 | 4.06% |
| 2033 | ₹205.23 | 10.16% |
| 2034 | ₹216.33 | 5.4% |
| 2035 | ₹241.25 | 11.51% |
| 2036 | ₹259.89 | 7.73% |
| 2037 | ₹263.5 | 1.38% |
| 2038 | ₹283.76 | 7.68% |
| 2039 | ₹296.26 | 4.4% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
AAREYDRUGS Past Performance
- In 2021, AAREYDRUGS opening price was ₹43.75
- As of Fri 22 Nov 2024 the price stands at ₹56.3.
- This represents a Compound Annual Growth Rate (CAGR) of 6.51%.
- In 3 years, an investment of 10,000 would have become ₹12,868.57.
As we wrap up, we hope you like our study on AAREYDRUGS share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
